Easy beer money to buy at 0003 and sell at 0004, rinse and repeat. It’s been churning in that range for months.

Nobody shorts penny stocks under $2.50 because under that threshold you’re required to have $2.50 margin for every share shorted.

Wanna short a million shares of $AHRO for $1,000? You need to have $2,500,000 collateral to do it.

No serious person with that much money is shorting penny stocks.

Share structure hasn’t changed in the last few days, so that’s good. Guess it’s just typical buy the rumor, sell the news. Sign of strength would be holding .0010 and churning below .0012 before the next leg up.

Think you nailed it. Can’t raise the AS or do a R/S without having current financials. The recent 10-Q is a bad sign in the world of pink sheets.

…I should have sold at 75%
I also should have just stayed in icbu.
Oh well, live and learn.

I mean, I know he said that on Twitter, but reading through the 10Q there are multiple notes that need to convert.

It’s classic pink sheet behavior; release some news, get some buys, and then convert notes.

Honestly, getting current with a 10Q is scary, because it’s usually a precursor to a R/S.

No. More likely a bunch of outstanding notes converted.

Any idea why I can’t see L2 data for DKSC? I can see it for any other stock, but not this one.

Nobody shorts penny stocks under $2.50 because you’re required to put up $2.50 for every share shorted.

Wanna short a million shares of $DKSC for $1,000? You need to have $2,500,000 collateral to do it.

No serious person with that much money is shorting penny stocks.

I’m old enough to remember when this was a doll company. Now they’re gonna be AI? Lol. Sure.

With an OS of 1.2 Billion shares?
A $6 PPS would make the company worth $7.2 Billion
Not bloody likely.

Only 120% more to reach my break even…

What is SRM, and why did he blur it out (poorly) on some bags but not others?

Did they really just PR the Dreamcard again?! No wonder it’s dumping.

GDET is going to spike like BMIX did.
Give it about 2 weeks to settle out from the spike last week, then one day we’ll wake up and see .03 to .05 and everyone will get paid.

I searched other biotechs for the phrase “identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments at this time.”

This is what I found:

Cosmo Pharma drug Methylene Blue MMX
Status: FDA CRL, repeat Phase 3

$ATRS drug XYOSTED
Status: FDA Approved

Vanda Pharma drug Hetlioz (for jet lag)
Status: FDA denied

We *still* don’t have an attorney letter. Next catalyst? Usually get a pretty good bump when those post.

It has nothing to do with nature. It’s all about volume levels of support and resistance.

If a stock gaps up on ultra low volume, then there’s not enough people holding shares to create a new level of support.

We traded more than 2 Billion shares today. The floor is set.

Is it too much to ask for GDET to make an MJWL move?

Not great, but it means their large increase in backlog came from somewhere else, which is good for the Large Contract Theory.

The Hololens platform does have the ability to simulate missions for soldiers to practice before they actually deploy.

Seal Team 6 built a mock-up of the entire Bin Laden compound to practice every step of the mission to kill him.

https://www.cnet.com/news/bing-map-shows-cias-secret-bin-laden-compound-mock-up/

Not only will HoloLenses make training for missions faster, without having to wait for entire mock cities to be constructed, but having an effective recoil kit on your weapon to accurately simulate firing it would make sense.

Depends on the size of their second shift, but I don’t think $8 to $10M would be unreasonable if first shift stays consistent at about $6M and second shift makes up the rest.

Now imagine the Border Patrol sole source RFP gets executed at about $8M, and they also get a follow-on booking from the secret-squirrel contract that booked that $1M increase to the backlog, and it’s no wonder they’re adding a second shift; they’re just a few months away from the largest bookings and backlog in company history.

...In fact, the fruits of that labor have started to show up in our backlog in a material way"

Anything Material is required to be recorded in the filing...

Exactly!
Now let’s look at 3 things:
- Revenues: Work completed that is no longer part of the backlog.
- Bookings: New orders added to the backlog.
- Backlog: Roughly the difference between revenues and bookings.

Over the last year their revenues have been relatively flat, they’re pumping out the same amount of work day in and day out, but suddenly their bookings are increasing and exploding their backlog.

That’s why they’re adding a second shift, and that why he’s saying “the fruits of our labor are starting to show up in our backlog in a material way.”

He can’t tell us where the money is coming from, but he’s holding a giant neon and blinking sign that says, “LOOK AT ALL THIS MONEY COMING IN FOOL!”

If Q2 shows the backlog increase by millions (again) instead of thousands, and in spite of increased revenues from the addition of a second shift that should be decreasing the backlog, it will be undeniable that they are neck deep in massive contract work that they just can’t talk about.

—————————

Mar 2021 Backlog - $16.1M +$1.5M
Mar 2021 Booking - $7.4M
Mar 2021 Revenue - $4.4M

Dec 2020 Backlog - $14.6M +$0.2M
Dec 2020 Booking - $5.5M
Dec 2020 Revenue - $6.5M

Sep 2020 Backlog - $14.4M +$0.1M
Sep 2020 Booking - $6.5M
Sep 2020 Revenue - $6.4M

Jun 2020 Backlog - $14.3M +$3.0M
Jun 2020 Booking - $5.9M
Jun 2020 Revenue - $2.7M

Mar 2020 Backlog - $11.3M

That’s pretty bad reporting, they haven’t won anything, it’s an RFP with a max allowed value of $24.5M.

VirTra could price out the bill of materials at $8M for all we know.

It is absolutely good news....but the company isn’t going to talk about it until the government accepts their proposed pricing and signs on the dotted line. Just the way it is.

Exactly, which is what the CEO has talked about in the past. He doesn’t want to give competitions a reason to raise the red flag, so he flat refuses to talk and speculate about RFPs and potential future business.

The good news, though, is that if you look through government spending history, Border Patrol has been one of their bigger repeat customers. They obviously love the VirTra product and sole source makes it seamless to integrate into their existing training.

I doubt they talk about it. For one, it’s just an RFP and could be canceled or modified at any point; sole source doesn’t guarantee money. Until there’s a signed contract they’ll likely avoid talking about it altogether.

Yeah, value of the systems are between $200k and $500k including most of the listed accessories. I’d ballpark the value of this contract at no more than $8M.

The $24.5M figure is either just the budget they had to work with, or a paperwork threshold (meaning a sole source contract over $24.5M would need additional forms and approvals, so they capped it there.)

As a publicly traded company, I’m not sure how they could continue to hide major financial news from the shareholders?

If there’s been a contract, or a subcontract, executed, they might not be able to talk about the specifics like who they’re working with and what their role is, but they should be required to disclose a number in their backlog?

In the last 10k it was just over $16M, if that number doesn’t change by more than a couple hundred thousand, I’ll question whether or not there’s a large contract at all.

No pricing on the order, but you have to figure upgrades to 2 systems and then multi year service agreements are gonna run between $500,000 and $800,000.

FDA isn’t asking for more research or trials though, just more time to review what they already have. It’s not an ITRM problem, it’s an FDA problem.

Relypsa was projected to bring in peak annual sales of $1B and got bought out 9 months after FDA approval for $1.5 Billion.

Their competitor ZS-9 had similar projections and was bought for $2.7 Billion even before FDA approval.

The current PPS and market cap of ITRM is a gift for anyone willing to buy and hold for the next 6 months to a year.

Because the market is more cynical than management. Also, ITRM can’t wait until FDA approval to start the ball rolling on sales and distribution; they need to start now so that when approval comes they’re ready.

Once the current offering closes, we won’t have another one for at least 2 months. Also, now that we’re above $1, if we stay above for the next 10 trading days, we regain NASDAQ compliance.

Expect both of those news events to drive the price over $2 and maybe even squeeze towards $3.

I really hate these computer generated reports as if they’re legitimate analysis.

The filing says he has the option to buy 25 million shares at .00001 each. That’s $250.

Then he can turn around and dump them on shareholders at the current PPS for $55,000.

I don’t see how this is good for the company at all. Makes it look a lot like a share selling scheme, not unlike the scam shippers.

Market Cap
17,081,887

Authorized Shares
2,000,000,000

Outstanding Shares
1,620,672,390

Restricted
22,931,494

Unrestricted
1,597,740,896

Float
1,364,811,408

I read it wrong, the $5M to $25M checked box said “Issuer Size” or company size, and I read it as “offering size.”

Form D - Up to $25,000,000 offering. Time to bail out?

https://newsfilter.io/articles/d-form---notice-of-exempt-offering-of-securities-items-06c-and-4a5---solar-integrated-roofing-corp-0-773ed21acde3abf3fb176efe6967273e